EX-32.1 4 v356325_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The undersigned, Eugene Seymour, MD, Chief Executive Officer of NanoViricides, Inc., hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) the annual report on Form 10-K/A of NanoViricides, Inc. for the period ended June 30, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of NanoViricides, Inc. 

 

Date: October 8, 2013 /s/ Eugene Seymour, MD
  Name: Eugene Seymour, MD
  Title: Chief Executive Officer and Director
  (Principal Executive Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to NanoViricides, Inc. and will be retained by NanoViricides, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.